Jpmorgan Chase & Co - 30 Jun 2025 SCHEDULE 13G/A Report for Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares

Filing Manager: Jpmorgan Chase & Co
Reporting Manager: JPMORGAN CHASE & CO.
Security: Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares
Shares outstanding: 2.45B shares
Disclosed Ownership: 220M shares
Ownership: 9%
Form type: SCHEDULE 13G/A
Date filed: 16 Jul 2025, 09:34
Date of event: 30 Jun 2025
Previous filing: 11 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	9%	220M	220M	0	Rachel Tsvaygoft	Vice President